Cargando…

Blood based biomarkers for movement disorders

Movement disorders have been carefully clinically defined, based on clinico‐pathological series; however there is often diagnostic and prognostic uncertainty, especially in early stage disease. Blood‐based biomarkers for Alzheimer's disease (AD), particularly p‐tau181 and p‐tau217, may be usefu...

Descripción completa

Detalles Bibliográficos
Autor principal: Morris, Huw R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828103/
https://www.ncbi.nlm.nih.gov/pubmed/36156206
http://dx.doi.org/10.1111/ane.13700